3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
25
Burkitt Lymphoma
15
Sarcoma
14
Neoplasms
11
Lymphoma, Follicular
11
Lymphoma
11
Hodgkin Disease
10
Breast Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Non-Hodgkin
9
Triple Negative Breast Neoplasms
8
Ovarian Neoplasms
8
Endometrial Neoplasms
8
Lymphoma, B-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Recurrence
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm Metastasis
5
Fallopian Tube Neoplasms
5
Wilms Tumor
4
Osteosarcoma
4
Lymphoma, Mantle-Cell
4
Liposarcoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Sarcoma, Ewing
3
Neuroblastoma
3
Lymphoproliferative Disorders
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia
3
Interventions
Cisplatin
22
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Platinum
12
Radiotherapy, Intensity-Modulated
11
1,2-diaminocyclohexaneplatinum II citrate
11
Radiotherapy
10
Radiation
10
Carboplatin
9
Surveys and Questionnaires
5
Biopsy
5
pembrolizumab
4
Taxes
4
Paclitaxel
4
Nivolumab
4
Docetaxel
4
Chemoradiotherapy
4
Cetuximab
4
Observation
3
Fluorodeoxyglucose F18
3
(225)Ac-DOTA-c(RGDyK)
3
durvalumab
2
X-Rays
2
Watchful Waiting
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Doxorubicin
×
90 days
×
Clear all
No trials found.